a year ago
SRPT
AnalystsBiren AminBiren Amin's Stock Forecasts
AnalystsBiren Amin
Analyst Ranking
Bottom 18%
#4309 out of 5216 analysts
Average Return
-0.38%
Win Rate
38%25 out of 66
Risk vs Reward
Poor
Good
Biren Amin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Context Therapeutics IncCNTX | +374.65% | $0.65 | $3.09 | 2025-06-26 - 2026-03-12 | Strong Buy |
Solid Biosciences IncSLDB | +178.34% | $2.77 | $7.71 | 2025-05-16 - 2026-03-12 | Strong Buy |
Allogene Therapeutics IncALLO | +159.18% | $0.95 | $2.47 | 2025-05-14 - 2026-03-12 | Strong Buy |
Opus Genetics IncIRD | +144.44% | $1.98 | $4.84 | 2025-11-25 - 2026-03-12 | Strong Buy |
Aclaris Therapeutics IncACRS | +120.75% | $1.59 | $3.51 | 2025-07-10 - 2026-03-12 | Strong Buy |
Biren Amin Analyst Color
Get additional color on Biren Amin's coverage of popular stocks
Biren Amin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $140.00 | +80.65% | Maintains | 15 days ago |
Okyo Pharma LtdOKYO | 1 | Strong Buy | $7.00 | +311.76% | Initiates Coverage On | 22 days ago |
Perspective Therapeutics IncCATX | 1 | Strong Buy | $16.00 | +213.11% | Initiates Coverage On | 23 days ago |
Opus Genetics IncIRD | 1 | Strong Buy | $7.00 | +44.63% | Initiates Coverage On | 4 months ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $48.00 | +100.00% | Initiates Coverage On | 4 months ago |
Sarepta Therapeutics IncSRPT | 12 | Hold | $16.00 | -6.10% | Maintains | 4 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $98.00 | +44.16% | Maintains | 4 months ago |
Lenz Therapeutics IncLENZ | 2 | Strong Buy | $67.00 | +466.84% | Maintains | 5 months ago |
Ocular Therapeutix IncOCUL | 2 | Strong Buy | $31.00 | +249.49% | Maintains | 5 months ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $95.00 | +64.93% | Maintains | 6 months ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $6.00 | +70.94% | Assumes | 8 months ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | $4.00 | +29.45% | Reiterates | 9 months ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $17.00 | +120.49% | Maintains | 10 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $7.00 | +183.40% | Maintains | 10 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $38.00 | +39.60% | Initiates Coverage On | a year ago |
Elevation Oncology IncELEV | 2 | Hold | $0.70 | +91.78% | Downgrades | a year ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $4.00 | N/A | Downgrades | a year ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Immunome IncIMNM | 3 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $115.00 | N/A | Maintains | a year ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $32.00 | N/A | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $70.00 | N/A | Maintains | 3 years ago |
Quince Therapeutics IncQNCX | 2 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 5 years ago |
Urovant Sciences LtdUROV | 1 | Hold | $16.25 | N/A | Downgrades | 5 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Kala Bio IncKALA | 2 | Hold | $500.00 | N/A | Downgrades | 5 years ago |
Immatics NvIMTX | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Strong Buy | $54.00 | N/A | Initiates Coverage On | 6 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | $10.00 | N/A | Downgrades | 6 years ago |
Calithera Biosciences IncCALA | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 6 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $492.00 | N/A | Upgrades | 6 years ago |
Synthorx IncTHOR | 1 | Hold | $68.00 | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Hold | $2,400.00 | N/A | Downgrades | 8 years ago |
Armo Biosciences IncARMO | 1 | Hold | $50.00 | N/A | Downgrades | 8 years ago |
Bluebird Bio IncBLUE | 4 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $101.00 | N/A | Initiates Coverage On | 8 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $69.00 | N/A | Maintains | 8 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $155.00 | N/A | Initiates Coverage On | 9 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Minerva Neurosciences IncNERV | 4 | Strong Buy | $136.00 | N/A | Initiates Coverage On | 9 years ago |
Obseva SaOBSVF | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.